Manganese

Manganese is one of the most paradoxical trace minerals. It is essential for life — required for bone formation, antioxidant defense, and brain metabolism — yet its toxicity is well-documented in industrial settings, where inhalation of manganese dust causes a parkinsonism-like syndrome called manganism. This dual nature makes manganese supplementation a careful balancing act: enough to support enzyme function, but not so much that accumulation becomes harmful.

The primary enzymatic role is in the mitochondria. Manganese superoxide dismutase (MnSOD) is the only enzyme in the mitochondrial matrix that neutralizes superoxide radicals, converting them to hydrogen peroxide, which is then cleared by catalase and glutathione peroxidase. Without adequate manganese, mitochondrial oxidative stress increases, potentially accelerating cellular aging and contributing to chronic disease. Manganese is also required for arginase (urea cycle function), pyruvate carboxylase (glucose production), and several glycosyltransferases that build the proteoglycan matrix of bone and cartilage.

Aschner’s 2017 review in Advances in Nutrition provides the most comprehensive modern overview of manganese biology. The article documents that dietary manganese deficiency is rare in humans because the mineral is widely distributed in foods — nuts, whole grains, legumes, and tea are particularly rich sources. Documented deficiency cases have occurred primarily in people on total parenteral nutrition without manganese supplementation, and in individuals with severe malabsorption. Symptoms include bone demineralization, skin rash, impaired wound healing, and altered glucose tolerance.

The bone health evidence is modest but interesting. Strause’s 1994 study showed that a combination of manganese (5 mg), copper, and zinc with calcium improved bone mineral density in postmenopausal women more than calcium alone. However, this was a multi-mineral combination, and the specific contribution of manganese cannot be isolated. No large RCT has tested standalone manganese for osteoporosis.

The honest framing must address the toxicity concern. Unlike many trace minerals where the gap between therapeutic and toxic doses is wide, manganese’s safety margin is narrower. The tolerable upper intake level is 11 mg/day for adults. Chronic high-dose supplementation, particularly in people with liver disease (which impairs manganese excretion via bile), can lead to accumulation in the basal ganglia and neurological symptoms resembling Parkinson’s disease. This is primarily a concern with industrial inhalation exposure, but it means manganese supplements should not be taken casually or at high doses.

Practical guidance: Most people do not need manganese supplements. The typical Indian diet provides 2–5 mg daily from grains, legumes, nuts, and tea. If supplementation is desired — for example, as part of a bone-support multi-mineral formula — doses of 2–5 mg are reasonable. Do not exceed 11 mg/day. Take with food to reduce nausea. Separate from iron supplements by 2–4 hours. If you have liver disease, a movement disorder, or work in an occupation with manganese exposure (welding, mining, steel production), consult a physician before supplementing.